![patricia_resa_edited.jpg](/sites/default/files/styles/1_1_small/public/imports/dest/drupal7_imatges/patricia_resa_edited.jpg?h=0ad36000&itok=Y2zQ0UmF)
Patricia Resa Infante
Patricia Resa-Infante is a molecular virologist. Born in Barcelona, she completed her doctoral thesis at the National Biotechnology Centre (attached to CSIC). She launched her research career investigating the flu virus in two postdoctoral stays abroad: at the Heinrich Pette Institute/Leibniz Institute for Experimental Virology in Hamburg (Germany), funded by a grant from the Humboldt Foundation; and at the European Molecular Biology Laboratory in Grenoble (France). She has also been on stays at other international centres, including the University of Oxford (UK) and Harvard Medical School (USA).
Since early 2018 she has been employed by IrsiCaixa, where she focuses on research into HIV-1 molecular capture and endocytic mechanisms in dendritic cells associated with the host-cell exosome pathway and continues her research into virus replication mechanisms aimed at developing new strategies to fight infectious processes.
Preclinical development of humanized monoclonal antibodies against CD169 as a broad antiviral therapeutic strategy.
Understanding the neurological implications of acute and long COVID using brain organoids.
Role of Siglecs in viral infections: A double-edged sword interaction.
Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors.
Structural and functional characterization of an influenza virus RNA polymerase-genomic RNA complex.